Alloy vs Vitara RX
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Alloy
Best for women in menopause/perimenopause who want a Menopause Society-certified clinician AND the broadest brand+compounded GLP-1 formulary in our directoryStarting at $80/mo
Vitara RX
Best for Cost-sensitive patients seeking the lowest flat-rate compounded GLP-1 pricing from a LegitScript-certified marketplace with a named 503A pharmacy, who are comfortable with a marketplace model lacking a named medical director and a strict no-refunds policy.Starting at $99/mo
Side-by-Side Comparison
| Feature | Alloy | Vitara RX |
|---|---|---|
| Overall Score | 7.4/10 | 7.4/10 |
| Starting Price | ✓$80/mo | $99/mo |
| Editorial Rating | 3.7 ★ /5 | 3.7 ★ /5 |
| Features | 8 features | ✓9 features |
| States Available | 0 | ✓49 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | ✓ Yes | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Alloy
Pros
- ✓Broadest GLP-1 formulary in our catalog: brand Wegovy + brand Zepbound + oral Wegovy + compounded semaglutide + compounded tirzepatide + compounded liraglutide
- ✓All consulting doctors are certified by The Menopause Society — only ~1,000 such certified practitioners exist among ~20,000 OB-GYNs in the US
- ✓Brand-name Wegovy starting at $199/mo and compounded liraglutide starting at $80/mo cover both ends of the price/access spectrum
- ✓STARTGLP1 promo code knocks $50 off the first month per the public site
Cons
- ✗Not available in Louisiana or Mississippi (verified) — readers in those two states should be routed elsewhere
- ✗Initial consultation is $49 and is separate from medication cost — readers should know there's a non-refundable upfront fee
- ✗Menopause-specialty framing — best fit for women in menopause/perimenopause, not the right product for men or younger women whose primary need is weight loss
Vitara RX
Pros
- ✓Among the lowest advertised flat pricing in the compounded GLP-1 market — $99/mo semaglutide and $149/mo tirzepatide with all doses same price
- ✓Named 503A pharmacy partner (Manifest Pharmacy, Greer SC) — disclosed verbatim in FAQ, increasing supply-chain transparency
- ✓LegitScript Certified with visible ID (50109579) on homepage
- ✓Explicit FDA compounded-drug disclaimer published verbatim on homepage and FAQ
- ✓Broad 49-state coverage with explicit state list (rather than vague 'most states' language)
- ✓Bundle includes consultation, medication, and shipping per homepage copy
Cons
- ✗No corporate legal entity (LLC/Inc/PC) disclosed in footer, terms, or privacy policy — only the trade name 'VitaraRx'
- ✗No named medical director or physician leadership — site states 'all clinical decisions are solely made by independent providers' (MD Integrations marketplace model)
- ✗All sales final per FAQ — 'Federal and State law do not allow medication returns. Therefore, all sales are final'
- ✗Pricing tiers appear to bundle all doses, but per-vial volume / mg quantity not clearly disclosed on homepage — buyers may be comparing apples-to-oranges vs other providers
- ✗Alaska excluded from shipping
- ✗Knoxville TN privacy-policy address does not match Georgia governing law or San Diego CA arbitration venue — geographically scattered legal posture
Our Verdict
Both Alloy and Vitara RX score equally well overall — the right choice depends on your priorities. Choose Alloy if you want women in menopause/perimenopause who want a Menopause Society-certified clinician AND the broadest brand+compounded GLP-1 formulary in our directory, or Vitara RX if Cost-sensitive patients seeking the lowest flat-rate compounded GLP-1 pricing from a LegitScript-certified marketplace with a named 503A pharmacy, who are comfortable with a marketplace model lacking a named medical director and a strict no-refunds policy. matters most to you.
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.